XOMA Flies On French Diabetes Deal
- Wednesday, January 5, 2011, 0:20
- Market
- Add a comment
Company announces that it will license its XOMA 052 diabetes drug to France’s Laboratoires Servier for $15 million.
http://www.forbes.com/2011/01/04/todays-big-gainers-xoma-pmc-marketnewsvideo.html?feed=rss_markets